Try The Drug Club risk-free for 30 days Trial terms

Allopurinol 100/300 mg tabs — Membership Pricing

Allopurinol 100/300 mg tabs is not confirmed for no-additional-cost pricing. Membership pricing may be available; confirm the price with the dispensing pharmacy.

Allopurinol 100/300 mg tabs Pricing

Pricing typePrice
TheDrugClubMembership pricing may be available
Typical Retail$37.00

Membership pricing may be available; confirm the price with the dispensing pharmacy.

About Allopurinol 100/300 mg tabs

Allopurinol 100/300 mg tabs is a prescription medication. Ask your doctor if Allopurinol 100/300 mg tabs is right for you.

Other strengths and forms of Allopurinol

Conditions Treated with Allopurinol 100/300 mg tabs

How to Check Allopurinol 100/300 mg tabs Pricing

  1. Join TheDrugClub for $19.95/month
  2. Receive your member card by email
  3. Present your card at a participating pharmacy
  4. Check active-formulary eligibility or available membership pricing

Allopurinol 100/300 mg tabs at Participating Pharmacies

Pharmacy participation and fulfillment options vary. Present your membership card and confirm current pricing before filling.

Related medications

Other medications associated with the same conditions in this catalog.

Also listed for Gout (Hyperuricemia)

What Allopurinol 100/300 mg tabs is approved for (FDA label)

Allopurinol tablets are indicated for: The management of adults with signs and symptoms of primary or secondary gout (acute attacks, tophi, joint destruction, uric acid lithiasis, and/or nephropathy) The management of adult and pediatric patients with leukemia, lymphoma and solid tumor malignancies who are receiving cancer therapy which causes elevations of serum and urinary uric acid levels The management of adult patients with recurrent calcium oxalate calculi whose daily uric acid excretion exceeds 800 mg/day in male patients and 750 mg/day in female patients, despite lifestyle changes (such as reduction of dietary sodium, non-dairy animal protein, oxalate rich foods, refined sugars and increases in oral fluids and fruits and vegetables) Limitations of Use Allopurinol tablets are not recommended for the treatment of asymptomatic hyperuricemia.

Source: Read the full FDA label on DailyMed. Label effective date: September 10, 2026.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Dosage forms and strengths for Allopurinol 100/300 mg tabs (FDA label)

Allopurinol Tablets, USP are available containing 100 mg of allopurinol, USP. The 100 mg tablets are white, round, functionally scored tablets debossed with M to the left of the score and 31 to the right of the score on one side of the tablet and blank on the other side. Tablets: 100 mg functionally scored .

Source: FDA prescribing information (DailyMed). Set ID: 8f50e91e-66a7-4fd4-888a-9f1986aa661c. SPL document ID: 5b231ff5-2257-6463-e063-6294a90ab02b. Label effective date: September 10, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Adverse reactions for Allopurinol 100/300 mg tabs (FDA label)

The following clinically significant adverse reactions are described elsewhere in the labeling: Skin Rash and Hypersensitivity [see Warnings and Precautions (5.1) ] Nephrotoxicity [see Warnings and Precautions (5.3) ] Hepatoxicity [see Warnings and Precautions (5.4) ] Myelosuppression [see Warnings and Precautions (5.5) ] Potential Effect on Driving and Use of Machinery [see Warnings and Precautions (5.6) ] The following adverse reactions associated with the use of allopurinol tablets were identified in literature, unpublished clinical trials or postmarketing reports. Because some of these reactions were reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. The most frequent adverse reaction to allopurinol tablets is skin rash. Most Common Adverse Reactions (≥ 1%) Gastrointestinal: Diarrhea, nausea, alkaline phosphatase increase, AST/ALT increase.

Source: FDA prescribing information (DailyMed). Set ID: 8f50e91e-66a7-4fd4-888a-9f1986aa661c. SPL document ID: 5b231ff5-2257-6463-e063-6294a90ab02b. Label effective date: September 10, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Contraindications for Allopurinol 100/300 mg tabs (FDA label)

Allopurinol tablets are contraindicated in patients with a history of hypersensitivity reaction to allopurinol or to any of the ingredients of allopurinol tablets. Known hypersensitivity to allopurinol or to any of the ingredients of allopurinol tablets .

Source: FDA prescribing information (DailyMed). Set ID: 8f50e91e-66a7-4fd4-888a-9f1986aa661c. SPL document ID: 5b231ff5-2257-6463-e063-6294a90ab02b. Label effective date: September 10, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Warnings and precautions for Allopurinol 100/300 mg tabs (FDA label)

Skin Rash and Hypersensitivity: Allopurinol has been associated with serious and sometimes fatal dermatological reactions. Discontinue allopurinol tablets at the first appearance of skin rash or other signs of hypersensitivity reaction. ( 5.1 ) Gout Flares: May occur during initiation of treatment. Concurrent prophylactic treatment with colchicine or anti-inflammatory agents is recommended. ( 5.2 ) Nephrotoxicity: Allopurinol may affect kidney function. Patients with decreased kidney function require lower doses of allopurinol tablets. ( 5.3 ) Hepatoxicity: Cases of reversible hepatotoxicity have occurred.

Source: FDA prescribing information (DailyMed). Set ID: 8f50e91e-66a7-4fd4-888a-9f1986aa661c. SPL document ID: 5b231ff5-2257-6463-e063-6294a90ab02b. Label effective date: September 10, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Drug interactions for Allopurinol 100/300 mg tabs (FDA label)

The following drugs may increase the risk of serious skin reactions: bendamustine, thiazide diuretics, ampicillin and amoxicillin. ( 7.1 ) Capecitabine: Avoid concomitant use. ( 7.2 ) Mercaptopurine or Azathioprine: Reduce mercaptopurine or azathioprine dose as recommended in the respective prescribing information. ( 7.2 ) Pegloticase: Discontinue and refrain from initiating treatment with allopurinol tablets. ( 7.2 ) See FPI for complete list of significant drug interactions. ( 7.2 ) 7.1 Drugs Known to Affect the Occurrence of Skin Rash and Hypersensitivity Concomitant use of the following drugs may increase the risk of skin rash, which may be severe: bendamustine, thiazide diuretics, ampicillin and amoxicillin.

Source: FDA prescribing information (DailyMed). Set ID: 8f50e91e-66a7-4fd4-888a-9f1986aa661c. SPL document ID: 5b231ff5-2257-6463-e063-6294a90ab02b. Label effective date: September 10, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Start Your Risk-Free Trial
Start Your Risk-Free Trial